A detailed history of Russell Investments Group, Ltd. transactions in Guardant Health, Inc. stock. As of the latest transaction made, Russell Investments Group, Ltd. holds 39,395 shares of GH stock, worth $1.19 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
39,395
Previous 38,060 3.51%
Holding current value
$1.19 Million
Previous $1.1 Million 17.83%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$22.3 - $36.29 $29,770 - $48,447
1,335 Added 3.51%
39,395 $903,000
Q2 2024

Aug 08, 2024

BUY
$16.07 - $31.84 $498 - $987
31 Added 0.08%
38,060 $1.1 Million
Q1 2024

May 08, 2024

SELL
$17.13 - $26.91 $230,364 - $361,885
-13,448 Reduced 26.12%
38,029 $784,000
Q4 2023

Feb 05, 2024

SELL
$21.58 - $29.5 $1.03 Million - $1.41 Million
-47,916 Reduced 48.21%
51,477 $1.39 Million
Q3 2023

Nov 13, 2023

SELL
$25.8 - $39.97 $758,236 - $1.17 Million
-29,389 Reduced 22.82%
99,393 $2.95 Million
Q2 2023

Aug 10, 2023

SELL
$20.94 - $38.01 $400,414 - $726,827
-19,122 Reduced 12.93%
128,782 $4.61 Million
Q1 2023

May 09, 2023

BUY
$22.92 - $33.76 $3.38 Million - $4.98 Million
147,446 Added 32193.45%
147,904 $3.47 Million
Q1 2022

May 05, 2022

SELL
$48.25 - $100.49 $145,039 - $302,072
-3,006 Reduced 86.78%
458 $30,000
Q3 2021

Nov 08, 2021

SELL
$98.77 - $132.17 $53,039 - $70,975
-537 Reduced 13.42%
3,464 $432,000
Q2 2021

Aug 04, 2021

SELL
$109.77 - $165.68 $227,004 - $342,626
-2,068 Reduced 34.07%
4,001 $495,000
Q1 2021

May 10, 2021

BUY
$127.04 - $179.1 $539,792 - $760,995
4,249 Added 233.46%
6,069 $924,000
Q4 2020

Feb 08, 2021

SELL
$99.96 - $135.93 $29,588 - $40,235
-296 Reduced 13.99%
1,820 $234,000
Q3 2020

Nov 09, 2020

BUY
$80.32 - $111.8 $146,182 - $203,476
1,820 Added 614.86%
2,116 $236,000
Q1 2020

May 06, 2020

BUY
$59.04 - $88.81 $17,475 - $26,287
296 New
296 $20,000

Others Institutions Holding GH

About Guardant Health, Inc.


  • Ticker GH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 102,220,000
  • Market Cap $3.09B
  • Description
  • Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...
More about GH
Track This Portfolio

Track Russell Investments Group, Ltd. Portfolio

Follow Russell Investments Group, Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Russell Investments Group, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Russell Investments Group, Ltd. with notifications on news.